Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2004 3
2005 2
2006 1
2007 1
2008 1
2009 1
2010 2
2011 1
2012 6
2013 6
2014 8
2015 5
2016 11
2017 11
2018 14
2019 17
2020 10
2021 15
2022 26
2023 16
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
Fair global drug pricing.
Campbell JD, Kaló Z. Campbell JD, et al. Among authors: kalo z. Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):581-583. doi: 10.1080/14737167.2018.1524296. Epub 2018 Sep 28. Expert Rev Pharmacoecon Outcomes Res. 2018. PMID: 30215535 No abstract available.
Can cost-effectiveness principles be ignored in urgent times?
Kaló Z, Németh B, Zemplényi A. Kaló Z, et al. J Comp Eff Res. 2022 Jan;11(1):7-9. doi: 10.2217/cer-2021-0211. Epub 2021 Oct 20. J Comp Eff Res. 2022. PMID: 34668766 Free PMC article. No abstract available.
Healthcare financing in Egypt: a systematic literature review.
Fasseeh A, ElEzbawy B, Adly W, ElShahawy R, George M, Abaza S, ElShalakani A, Kaló Z. Fasseeh A, et al. Among authors: kalo z. J Egypt Public Health Assoc. 2022 Jan 7;97(1):1. doi: 10.1186/s42506-021-00089-8. J Egypt Public Health Assoc. 2022. PMID: 34994859 Free PMC article. Review.
Beyond medicines' barriers: exploring the true cost of multiple myeloma.
Choon-Quinones M, Zelei T, Barnett M, Keown P, Durie B, Kaló Z, Almási T, Harousseau JL, Hose D. Choon-Quinones M, et al. Among authors: kalo z. J Med Econ. 2022 Jan-Dec;25(1):1167-1175. doi: 10.1080/13696998.2022.2133823. J Med Econ. 2022. PMID: 36397678 Free article. Review.
Maximizing the benefits of using biosimilars in Egypt.
Fasseeh AN, Elezbawy B, El-Fass KA, GamaI M, Seyam A, Hayek N, Abdel Rahman N, Abdelhamid S, Fasseeh N, Saad AS, Elagamy A, Mahmoud A, Sedrak AS, Elshazly K, Eldebeiky M, Talaat M, Mohamed NM, Abdelaziz RA, Refaat R, Akeel S, Abaza S, Kaló Z. Fasseeh AN, et al. Among authors: kalo z. J Pharm Policy Pract. 2023 Jun 26;16(1):79. doi: 10.1186/s40545-023-00581-w. J Pharm Policy Pract. 2023. PMID: 37365620 Free PMC article.
Need for multicriteria evaluation of generic drug policies.
Kaló Z, Holtorf AP, Alfonso-Cristancho R, Shen J, Ágh T, Inotai A, Brixner D. Kaló Z, et al. Value Health. 2015 Mar;18(2):346-51. doi: 10.1016/j.jval.2014.12.012. Epub 2015 Feb 11. Value Health. 2015. PMID: 25773570 Free article. Review.
Outcome-based reimbursement in Central-Eastern Europe and Middle-East.
Ádám I, Callenbach M, Németh B, Vreman RA, Tollin C, Pontén J, Dawoud D, Elvidge J, Crabb N, van Waalwijk van Doorn-Khosrovani SB, Pisters-van Roy A, Vincziczki Á, Almomani E, Vajagic M, Oner ZG, Matni M, Fürst J, Kahveci R, Goettsch WG, Kaló Z. Ádám I, et al. Among authors: kalo z. Front Med (Lausanne). 2022 Sep 23;9:940886. doi: 10.3389/fmed.2022.940886. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36213666 Free PMC article.
150 results